Pathfinder Cell Therapy, Inc. Share Price Other OTC
Equities
PFND
US70319A1060
Biotechnology & Medical Research
Sales 2013 | 0.05 4.51 | Sales 2014 | - | Capitalization | 534K 44.53M |
---|---|---|---|---|---|
Net income 2013 | -1M -83.43M | Net income 2014 | -1M -83.43M | EV / Sales 2013 | 24,60,23,185 x |
Net Debt 2013 | 3.94M 329M | Net Debt 2014 | 4.96M 414M | EV / Sales 2014 | - |
P/E ratio 2013 |
-5.48
x | P/E ratio 2014 |
-0.38
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/11/02 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/11/02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Franklin
CEO | Chief Executive Officer | 78 | 02/11/02 |
John Benson
DFI | Director of Finance/CFO | 62 | 02/11/02 |
1st Jan change | Capi. | |
---|---|---|
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |